Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Eur Heart J Case Rep ; 7(12): ytad579, 2023 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-38130861

RESUMO

Background: Mitral valve diseases are a common medical condition, and surgery is the most used therapeutic approach. The need for less invasive interventions led to the development of transcatheter valve implantation in high-risk patients. However, the treatment to the dysfunctions of these prosthetic valves is still uncertain, and the yield and safety of repeated transcatheter valve implantations remain unclear. Cases summary: A 69-year-old Caucasian woman with three previous mitral valve procedures performed due to rheumatic valve disease (currently with a biological prosthetic mitral valve) and a 76-year-old Latin woman with previous liver transplantation (due to metabolic-associated fatty liver disease) and biological mitral prosthesis due to mitral valve prolapse with severe regurgitation underwent mitral valve-in-valve (ViV) transcatheter implantation at the time of dysfunction of their surgical prostheses. Later, these patients developed prosthetic valve dysfunction and clinical worsening, requiring another invasive procedure. Due to maintained high-risk status and unfavourable clinical conditions for surgery, re-valve-in-valve (re-ViV) was performed. Discussion: Valve-in-valve transcatheter mitral valve implantation was approved in 2017, and, since then, it has been used in several countries, mainly in high-risk patients. Nevertheless, these prosthetic valves may complicate with stenosis or regurgitation, demanding reinterventions. Although there are favourable data for mitral ViV, re-ViV still lacks robust data to support its performance, with only case reports in the literature so far. It is possible that in high-risk patients, there is a greater benefit from re-ViV when compared with the surgical strategy. However, this hypothesis must be studied in future controlled trials.

2.
Rev. bras. educ. méd ; 37(4): 566-572, out.-dez. 2013. mapas, tab
Artigo em Português | LILACS | ID: lil-710121

RESUMO

O ensino médico há alguns anos vem passando por uma transição do modelo clássico teórico para abordagens práticas e baseadas em problemas. Fundamentando-se em uma abordagem prática ambulatorial, criou-se um projeto de extensão para o ensino simultâneo a alunos de diferentes anos do curso médico com uma população ribeirinha, em que cada acadêmico utilizou suas habilidades adquiridas no curso para a criação de um serviço ambulatorial (acolhimento, pré-consulta, consulta médica, vacinação e dispensação de medicamentos), de forma a promover um serviço de saúde. Esta ação ocorreu em áreas remotas da Amazônia brasileira, mostrando que é possível unir extensão e ensino na formação de médicos mais conscientes das diferentes realidades socioeconômicas e culturais brasileiras.


The model of medical education has been undergoing a transition between classical theory and problem-oriented teaching based in the past years. Relying on an outpatient practice, we created an outreach project for the simultaneous teaching of students from different years of the medical course integrated with the consultation of a riverside population, where each used their academic skills already acquired in the course to create an outpatient service (pre-consultation, medical consultation, vaccination and drug dispensing) in order to promote a health service. This action occurred in the most remote areas of the Brazilian Amazon, showing that it is possible to combine community outreach projects and teaching while making future medical doctors more aware of the different Brazilian socioeconomic and cultural realities.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA